What drives the inflammatory response in rhinosinusitis

Allergy and Asthma Proceedings

Volumn 27, Issue 6, 2006, Pages 441-446

  Weldon, David R ^a,b,c  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID;

ANIMAL; CONFERENCE PAPER; HUMAN; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; RHINITIS; SINUSITIS;

ANIMALS; HUMANS; INFLAMMATION MEDIATORS; RHINITIS; SINUSITIS;

EID: 33845490232     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2006.27.2925     Document Type: Conference Paper

References (62)

1. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: A practice parameter update. J Allergy Clin Immunol 116:S13-S47, 2005.
2. Chan KH, Abzug MJ, Coffinet L, et al. Chronic rhinosinusitis in young children differs from adults: A histopathology study. J Pediatr 144:206-212, 2004.
3. Pascual RM, and Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: An overview. J Allergy Clin Immunol 116:477-486, 2005.
4. Novak N, Bieber T, and Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 112:3128-5139, 2003.
5. Leung DY. Atopic dermatitis: New insights and opportunities for therapeutic intervention. J Allergy Clin Immunol. 105:860-876, 2000.
6. Suzuki H, Takahashi Y, Wataya H, et al. Mechanism of neutrophil recruitment induced by IL-8 in chronic sinusitis. J Allergy Clin Immunol. 98:659-670, 1996.
7. Pelikan Z, and Pelikan-Filipek M. Role of nasal allergy in chronic maxillary sinusitis-Diagnostic value of nasal challenge with allergen. J Allergy Clin Immunol. 86:484-491, 1990.
8. Leipzig JR, Martin DS, Eisenbeis JF, and Slavin RG. Computed tomographic study of the paranasal sinuses in allergic rhinitis. J Allergy Clin Immunol 98:1130-1131, 1996.
9. Slavin RG, Leipzig JR, and Goodgold HM. "Allergic sinusitis" revisited. Ann Allergy Asthma Immunol 85:273-276, 2000.
10. Berger G, Kattan A, Bernheim J, and Ophir D. Polypoid mucosa with eosinophilia and glandular hyperplasia in chronic sinusitis: A histopathological and immunohistochemical study. Laryngoscope 112:738-745, 2002.
11. Hamilos DL, Leung DY, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 96:537-544, 1995.
12. Steinke JW, Bradley D, Arango P, et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: Importance to eosinophilia and asthma. J Allergy Clin Immunol 111:342-349, 2003.
13. Borish L. Allergic rhinitis: Systemic inflammation and implications for management. J Allergy Clin Immunol 112:1021-1031, 2003.
14. Newman LJ, Platts-Mills TA, Phillips CD, et al. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 271:363-367, 1994.
15. ten Brinke A, Grootendorst DC, Schmidt JT, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 109:621-626, 2002.
16. Denburg JA, and Keith PK. Systemic aspects of chronic rhinosinusitis. Immunol Allergy Clin North Am 24:87-102, 2004.
17. Denburg JA, Sehmi R, Saito H, et al. Systemic aspects of allergic disease: Bone marrow responses. J Allergy Clin Immunol. 106: S242-S246, 2000.
18. Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 17:683-690, 1997.
19. Borish L, and Rosenwasser LJ. Cytokines in allergic inflammation. In Middleton's Allergy Principle & Practice, 6th ed. Chap. 10. Adkinson NF, Yunginger JW, Busse WW, et al. (Eds). Philadelphia: Mosby, 135-157, 2003.
20. Soussi-Gounni A, Kontolemos M, and Hamid Q. Role of IL-9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol 107:575-582, 2001.
21. Kuperman DA, Huang X, Koth LL, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8:885-889, 2002.
22. Wills-Karp M, and Karp CL. Chitin checking-Novel insights into asthma. N Engl J Med 351:1455-1457, 2004.
23. Borish L. The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 88:16-22, 2002.
24. Georgitis JW, Matthews BL, and Stone B. Chronic sinusitis: Characterization of cellular influx and inflammatory mediators in sinus lavage fluid. Int Arch Allergy Immunol 106:416-421, 1995.
25. Holgate ST, Peters-Golden M, Panettieri RA, and Henderson WR Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 111:S18-S34, 2003.
26. Vargaftig BB, and Singer M. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. Am J Respir Cell Mol Biol 28:410-419, 2003.
27. Cuzzocrea S, Rossi A, Mazzon E, et al. 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration. Lab Invest 85:808-822, 2005.
28. Durham SR, Gould HJ, Thienes CP, et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 27:2899-2906, 1997.
29. Drake-Lee AB, and McLaughlan P. Clinical symptoms, free histamine and IgE in patients with nasal polyposis. Int Arch Allergy Appl Immunol 69:268-271, 1982.
30. Small P, Barrett D, Frenkiel S, et al. Local specific IgE production in nasal polyps associated with negative skin tests and serum RAST. Ann Allergy 55:736-739, 1985.
31. Bernstein JM, and Kansal R. Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 13:39-44, 2005.
32. Schubert MS. A Superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 87:181-188, 2001.
33. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: An enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 114:1369-1375, 2004.
34. von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344:11-16, 2001.
35. Laouini D, Kawamoto S, Yalcindag A, et al. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol 112:981-987, 2003.
36. Leung DY, Harbeck R, Bina P, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 92:1374-1380, 1993.
37. Gevaert P, Holtappels G, Johansson SG, et al. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 60: 71-79, 2005.
38. Bernstein JM, Ballow M, Schlievert PM, et al. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 17:321-326, 2003.
39. Hauk PJ, Hamid QA, Chrousos GP, and Leung DY. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 105:782-787, 2000.
40. Strickland I, Kisich K, Hauk PJ, et al. High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 193:585-593, 2001.
41. Hamilos DL, Leung DY, Muro S, et al. GRbeta expression in nasal polyp inflammatory cells and its relationship to the antiinflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 108:59-68, 2001.
42. Li LB, Goleva E, Hall CF, et al. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J Allergy Clin Immunol 114:1059-1069, 2004.
43. Claeys S, Van Hoecke H, Holtappels G, et al. Nasal polyps in patients with and without cystic fibrosis: A differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 35:467-472, 2005.
44. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 107:607-614, 2001.
45. Hamilos DL, Leung DY, Muro S, et al. GRbeta expression in nasal polyp inflammatory cells and its relationship to the antiinflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 108:59-68, 2001.
46. Badia L, and Lunda V. Topical corticosteroid in nasal polyposis. Drugs 61:573-578, 2001.
47. Holmberg K, Juluisson S, Balder B, et al. Fluticasone proprionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 78:270-276, 1997.
48. Rhuno J, Andersson B, Denburg J, et al. A double blind comparison of intranasal budesonides with placebo for nasal polyposis. J Allergy Clin Immunol 86:946-953, 1990.
49. Chalton R, Mackay I, Wilson R, et al. Double blind, placebo controlled trial of betamethasone nasal drops for nasal polyposis. BMJ 29:788, 1985.
50. Tuncer U, Soylu L, Aydogan B, et al. The effectiveness of steroid treatment in nasal polyposis. Auris Nasus Larnyx 30:263-268, 2003.
51. Bonfils P, Nores JM, Halim P, and Avan P. Corticosteroid treatment in nasal polyposis with a three-year follow-up period. Laryngoscope 113:683-687, 2003.
52. Proud D. Biology of epithelial cells. In Middleton's Allergy Principles & Practice, 6th ed. Chap. 24. Adkinson NF, Yunginger JW, Busse WW, et al. (Eds). Philadelphia: Mosby, 373-384, 2003.
53. Reed CE, and Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114:997-1008, 2004.
54. Hoshino M, Takahashi M, and Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 107:295-301, 2001.
55. Powell PP, Klagsbrun M, Abraham JA, and Jones RC. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am J Pathol 143:784-793, 1993.
56. Rochester CL, Ackerman SJ, Zheng T, and Elias JA. Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol 156:4449-4456, 1996.
57. Schmid-Grendelmeier P, Altznauer F, Fischer B, et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 169:1021-1027, 2002.
58. Starnes T, Robertson MJ, Sledge G, et al. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 167:4137-4140, 2001.
59. Wong DT, Elovic A, Matossian K, et al. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood 78:2702-2707, 1991.
60. Puxeddu I, Ribatti D, Crivellato E, and Levi-Schaffer F. Mast cells and eosinophils: A novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 116: 531-536, 2005.
61. Molet SM, Hamid QA, and Hamilos DL. IL-11 and IL-17 expression in nasal polyps: Relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 113:1803-1812, 2003.
62. Ramadan HH. Corticosteroid therapy during endoscopie sinus surgery in children: Is there a need for a second look? Arch Otolaryngol Head Neck Surg 127:188-192, 2001.